GE HealthCare has brought a new premium PET/MR scanner to the exhibit hall at the annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Chicago.
GE HealthCare's new Signa PET/MR AIR scanner. Image courtesy of GE HealthCare.The new scanner -- called Signa PET/MR Air -- has been outfitted with the company's AIR technologies, including AIR Coils for improved patient comfort; AIR Recon DL for deep learning-based MR image quality improvement and up to 50% faster scan times; and MotionFree Brain software for mitigating motion-related PET image degradation, according to the vendor.
As was the case for the initial Signa PET/MR scanner, GE HealthCare is highlighting the system's time-of-flight (TOF) capabilities, which the company believes can aid clinicians in providing early diagnosis, assessing disease progression, and spotting adverse effects in patients with Alzheimer's disease.
The vendor is also talking up Signa PET/MR Air's utility for detecting and staging/re-staging prostate cancer, as well as helping to select patients for subsequent prostate-specific membrane antigen (PSMA)-targeted radioligand therapy.
In other SNMMI 2023 introductions, GE HealthCare is highlighting its technologies to support theranostics, as well as additional AI-based applications such as Precision DL, which recently garnered U.S. Food and Drug Administration clearance. Additionally, GE HealthCare said that it's conducting a phase I clinical trial of a fluorine-18 PET radiopharmaceutical targeted at CD8, which is expressed on CD8+ T cells that fight cancer.
